Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8 T Cells.

Hadi Karimzadeh, Muthamia M Kiraithe, Anna D Kosinska, Manuel Glaser, Melanie Fiedler, Valerie Oberhardt, Elahe Salimi Alizei, Maike Hofmann, Juk Yee Mok, Melanie Nguyen, Wim J E van Esch, Bettina Budeus, Jan Grabowski, Maria Homs, Antonella Olivero, Hossein Keyvani, Francisco Rodríguez-Frías, David Tabernero, Maria Buti, Andreas Heinold, Seyed Moayed Alavian, Tanja Bauer, Julian Schulze Zur Wiesch, Bijan Raziorrouh, Daniel Hoffmann, Antonina Smedile, Mario Rizzetto, Heiner Wedemeyer, Jörg Timm, Iris Antes, Christoph Neumann-Haefelin, Ulrike Protzer, Michael Roggendorf

Journal: Journal of virology 2018;92(13):e01891-17

PMID: 29669837

Abstract

Virus-specific CD8 T cell response seems to play a significant role in the outcome of hepatitis delta virus (HDV) infection. However, the HDV-specific T cell epitope repertoire and mechanisms of CD8 T cell failure in HDV infection have been poorly characterized. We therefore aimed to characterize HDV-specific CD8 T cell epitopes and the impacts of viral mutations on immune escape. In this study, we predicted peptide epitopes binding the most frequent human leukocyte antigen (HLA) types and assessed their HLA binding capacities. These epitopes were characterized in HDV-infected patients by intracellular gamma interferon (IFN-γ) staining. Sequence analysis of large hepatitis delta antigen (L-HDAg) and HLA typing were performed in 104 patients. The impacts of substitutions within epitopes on the CD8 T cell response were evaluated experimentally and by studies. We identified two HLA-B*27-restricted CD8 T cell epitopes within L-HDAg. These novel epitopes are located in a relatively conserved region of L-HDAg. However, we detected molecular footprints within the epitopes in HLA-B*27-positive patients with chronic HDV infections. The variant peptides were not cross-recognized in HLA-B*27-positive patients with resolved HDV infections, indicating that the substitutions represent viral escape mutations. Molecular modeling of HLA-B*27 complexes with the L-HDAg epitope and its potential viral escape mutations indicated that the structural and electrostatic properties of the bound peptides differ considerably at the T cell receptor interface, which provides a possible molecular explanation for the escape mechanism. This viral escape from the HLA-B*27-restricted CD8 T cell response correlates with a chronic outcome of hepatitis D infection. T cell failure resulting from immune escape may contribute to the high chronicity rate in HDV infection. Hepatitis delta virus (HDV) causes severe chronic hepatitis, which affects 20 million people worldwide. Only a small number of patients are able to clear the virus, possibly mediated by a virus-specific T cell response. Here, we performed a systematic screen to define CD8 epitopes and investigated the role of CD8 T cells in the outcome of hepatitis delta and how they fail to eliminate HDV. Overall the number of epitopes identified was very low compared to other hepatotropic viruses. We identified, two HLA-B*27-restricted epitopes in patients with resolved infections. In HLA-B*27-positive patients with chronic HDV infections, however, we detected escape mutations within these identified epitopes that could lead to viral evasion of immune responses. These findings support evidence showing that HLA-B*27 is important for virus-specific CD8 T cell responses, similar to other viral infections. These results have implications for the clinical prognosis of HDV infection and for vaccine development.

Copyright © 2018 American Society for Microbiology.

Address: Institute of Virology, Technical University of Munich/Helmholtz Zentrum München, Munich, Germany.; Institute of Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.; University Hospital Freiburg, Department of Medicine II, University of Freiburg, Faculty of Medicine, Freiburg, Germany.; Institute of Virology, Technical University of Munich/Helmholtz Zentrum München, Munich, Germany.; German Center for Infection Research (DZIF), Munich and Hannover Sites, Braunschweig, Germany.; Center for Integrated Protein Science Munich at the Department of Biosciences, Technische Universität München, Freising, Germany.; Institute of Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.; Sanquin, Amsterdam, The Netherlands.; Department of Bioinformatics, University of Duisburg-Essen, Essen, Germany.; German Center for Infection Research (DZIF), Munich and Hannover Sites, Braunschweig, Germany.; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; CIBERehd and Departments of Biochemistry/Microbiology and Hepatology, Vall d'Hebron Hospital, University Autònoma de Barcelona (UAB), Barcelona, Spain.; Department of Medical Sciences, University of Turin, Turin, Italy.; Department of Virology, Iran University of Medical Sciences, Tehran, Iran.; Institute of Transfusion Medicine, University of Duisburg-Essen, University Hospital, Essen, Germany.; Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran.; Department of Medicine, Section of Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; University Hospital Munich-Grosshadern, Department of Medicine II, Munich, Germany.; Institute of Virology, Heinrich-Heine-University, University Hospital, Duesseldorf, Germany.; Institute of Virology, Technical University of Munich/Helmholtz Zentrum München, Munich, Germany [email protected].; Institute of Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.; German Center for Infection Research (DZIF), Munich and Hannover Sites, Braunschweig, Germany.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.